The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.
population was expanded after the regulator okayed its use alongside Roche’s Rituxan (rituximab) for all relapsed/refractory CLL patients based on the MURANO trial results.
The PIX306 trial paired Pixuvri (pixantrone) – already sold in some European markets as a monotherapy for hard-to-treat NHL – with Roche’s MabThera (rituximab) and compared it to MabThera plus
now also be used in patients without that mutation, both alone and in combination with Rituxan. ... A similar marketing application is under review by the EMA. In MURANO, giving first-in-class BCL-2-targeting drug Venclexta (venetoclax) with anti-CD20
Roche’s ageing blockbuster MabThera has picked up a new approval in life-threatening skin disorder pemphigus vulgaris, becoming the first new treatment for the disease in six decades. ... MabThera (rituximab) – an anti-CD20 antibody known as Rituxan
The third of the big three - Mabthera/Rituxan (rituximab) - did not fare as well as its peers however, with sales down 8% to CHF 1.7bn overall and plummeting 44% in
[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...